SIRIO Europe launches LifeChews™ plant-based jelly tablets, redefining lipid-based supplementation

12 March 2026, Pritzwalk, Germany – SIRIO Europe, a leading global contract development and manufacturing organization (CDMO) specializing in advanced nutraceutical gummy and softgel solutions, today announces the launch of LifeChews™ – a patented, plant-based, chewable jelly tablet format. Clinically proven to significantly improve bioavailability, the format delivers excellent dispersibility across a wide range of oil-soluble actives while enabling high nutrient payloads. 

As part of the launch, SIRIO will unveil a range of turnkey concepts that harness this unique format, enabling brands to deliver supplements that are both effective and enjoyable – helping consumers build lasting health habits. 

Chewable convenience 

Sensory appeal and performance now lead decisions about supplement purchases globally, with 43% of consumers calling for greater efficacy and up to 45% citing pleasant taste as a key format driver. However, traditional formulation challenges, such as poor dispersibility, oxidation, and unpleasant aftertastes, have historically limited the development of lipid-based nutrient formulations in on-the-go, chewable formats.  

LifeChews™ meet these demands with a chewable, plant-based format that delivers high-strength, lipid-soluble nutrients in a delicious, easy-to-take form – making them suitable for many active ingredients including omega-3 oils, fat-soluble vitamins, CoQ10 and carotenoids such as lutein and astaxanthin. 

SIRIO has developed four market-ready concepts using this unique jelly tablet format, helping brands meet the growing demand for supplements that are both tasty and efficacious. The range addresses key consumer health priorities including brain health, heart health, immunity and longevity, showcasing how the jelly tablets can combine high-strength lipid nutrients with a convenient, enjoyable daily experience. 

Clinically proven performance 

The patented LifeChews™ technology ensures uniform dispersion of 5 μm oil droplets, comparable to lipid particle sizes found in human milk – optimizing absorption. In studies, LifeChews™ achieved a 161% higher blood plasma DHA concentration versus a control, representing a 198% improvement in bioavailability. Additional digestion studies confirmed even distribution of DHA during simulated gastric and intestinal conditions, highlighting the format’s stability and efficiency. 

For nutraceutical brands, this combination of scientific validation, high payload and consumer-friendly plant-based format provides clear differentiation in the rapidly growing, yet highly competitive omega-3 and lipid-based supplement categories. 

SIRIO’s next step in high-performance supplements 

“LifeChews™ are a gamechanger in how consumers experience supplements,” says Sara Lesina, General Manager, SIRIO Europe. “They combine convenience, great taste, and a really meaningful nutrient boost in a plant-based chewable jelly format people actually enjoy.”  

She continues, “By bringing together clinical validation and a high payload capacity, LifeChews™ give our partner brands a powerful new way to stand out in key trending categories and deliver real added value to consumers.”